☰

cached image

Pavan K. Auluck, MD PhD

Affiliations: 
Pathology Massachusetts Institute of Technology and Harvard Medical School and Masssachusetts General Hospital, Boston, MA, United States 
Area:
models of neurodegenerative disease
Google:
"Pavan Auluck"
Bio:

http://web.wi.mit.edu/lindquist/pub/NeurodegenDisease.html

http://www2.massgeneral.org/pathology/train/sp-lit.htm

Mean distance: 14.73 (cluster 24)
 		SNBCP
Tree Publications Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

Parents

Sign in to add mentor
Nancy Mara Bonini grad student 1998-2003 Penn
 (Modelling Parkinson's disease in Drosophila: The protective role of molecular chaperones.)
Matthew P. Frosch post-doc 2004- Massachusetts General Hospital & Harvard Medical School
Susan L. Lindquist post-doc 2008- Whitehead Institute (FlyTree)
E. Tessa Hedley-Whyte post-doc 2006-2008 Harvard Medical School and Masssachusetts General Hospital
David N. Louis post-doc 2006-2008 Massachusetts General Hospital & Harvard Medical School

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Weihofen A, Liu Y, Arndt JW, et al. (2018) Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models. Neurobiology of Disease
Chung CY, Khurana V, Yi S, et al. (2017) In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons. Cell Systems
Khurana V, Peng J, Chung CY, et al. (2017) Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways. Cell Systems
Caraveo G, Auluck PK, Whitesell L, et al. (2014) Calcineurin determines toxic versus beneficial responses to α-synuclein. Proceedings of the National Academy of Sciences of the United States of America. 111: E3544-52
Chung CY, Khurana V, Auluck PK, et al. (2013) Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons. Science (New York, N.Y.). 342: 983-7
di Tomaso E, Snuderl M, Kamoun WS, et al. (2011) Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Research. 71: 19-28
Auluck PK, Caraveo G, Lindquist S. (2010) α-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annual Review of Cell and Developmental Biology. 26: 211-33
Su LJ, Auluck PK, Outeiro TF, et al. (2010) Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Disease Models & Mechanisms. 3: 194-208
Steele AD, Zhou Z, Jackson WS, et al. (2009) Context dependent neuroprotective properties of prion protein (PrP). Prion. 3: 240-9
Yeger-Lotem E, Riva L, Su LJ, et al. (2009) Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nature Genetics. 41: 316-23
See more...